USPTO serial 79386846
DELUSEE
Reviewed by CopyMark Law Group
Status 692
- Filing date
- Status date
- Registration date
- —
- Examiner
- BROWNING, KATHRYN ELISABETH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DELUSEE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Justin Brown
Justin Brown Brown Brothers Law LLP1827 harley driveAnn Arbor, MI 48103United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Personal deodorants and antiperspirants; Non-medicated toiletry preparations; Non-medicated grooming preparations in the nature of shampoos for animals; Essential oils and aromatic extracts in the nature of aromatic oils; Household fragrances; Non-medicated body cleaning and beauty care preparations, namely, shower gels, body wash, soaps, facial cleansers, body scrubs, exfoliating cleansers, moisturizing lotions, face creams, body lotions, hand and body creams, deodorants, antiperspirants, foot creams, face masks, makeup removers, skin toners, skin serums, eye creams, lip creams and balms, shower oils and body butters; Non-medicated skin, eye and nail care preparations; Non-medicated hair care preparations and treatments, namely, shampoos, conditioners, hair masks and hair serums; Oral hygiene preparations, namely, non-medicated mouthwashes, toothpastes, tooth whitening gels, mouth gels, non-medicated mouthwash; Hair removing creams and gels and shaving preparations; Bath preparations, not for medical purposes; Perfumery and fragrances; Make-up; Cosmetic soaps and cosmetic gels; Cosmetic breast firming preparations; Concealers for facial lines and wrinkles; Wrinkle removing skin care preparations; Anti-aging skincare preparations, namely creams | ACTIVE | — |
| 005 | Biological implants, namely, a vital processed human or animal connective tissue; Surgical implants comprised of living tissues; Surgical implants grown from stem cells being living tissues; Pharmaceutical implants, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for pain management, cancer treatment or prevention, hormone replacement therapy, contraception, addiction treatment, Parkinson's disease symptom management, diabetes management, osteoporosis treatment, cardiovascular disease treatment or prevention, antibiotic delivery, seizure control in epilepsy, mental health conditions, weight management and obesity treatment, vitamin and nutrient supplementation, HIV/AIDS treatment, growth hormone deficiency, Alzheimer's disease symptom management, immune modulation for autoimmune conditions, menopause symptom relief and allergy desensitization therapy; Dermatological pharmaceutical products; Dermatological pharmaceutical substances, namely, pharmaceutical preparations for skincare and body care; Dermatological preparations, namely, pharmaceutical preparations for skincare and body care; Skin hydrators being injectable dermal fillers; Injectable pharmaceuticals, namely, injectable dermal fillers, for skin moisturisation and reduction of wrinkles; Anti-ageing pharmaceuticals, namely, pharmaceuticals for the treatment of loss of skin elasticity, sagging skin, age spots and hyperpigmentation, dehydrated or dry skin, reduced collagen production, thinning skin, bone density loss, weakened immune system, cognitive decline, hair thinning or loss, memory loss, oxidative stress and free radical damage; pharmaceuticals for the treatment of glabellar lines and facial wrinkles, asymmetries, defects and diseases of the human skin; Injectable dermal fillers in gel form for wrinkle filling for medical purposes; Injectable gels for surgical and orthopaedic purposes for the treatment and repair of joint cartilage, for the treatment and removal of human skin defects, for body and facial contouring, and for the removal of body and facial asymmetries; Replacement surgical implants comprising living tissue for joint fluids and soft body tissues; Pharmaceutical products in gel form for pain management, cancer treatment or prevention, hormone replacement therapy, contraception, addiction treatment, Parkinson's disease symptom management, diabetes management, osteoporosis treatment, cardiovascular disease treatment or prevention, antibiotic delivery, seizure control in epilepsy, mental health conditions, weight management and obesity treatment, vitamin and nutrient supplementation, HIV/AIDS treatment, growth hormone deficiency, Alzheimer's disease symptom management, immune modulation for autoimmune conditions, menopause symptom relief and allergy desensitization therapy; Pharmaceutical preparations, namely, gel solutions for wrinkle smoothing; pharmaceuticals, namely, injectable gel volume fillers for body contouring and for correcting soft tissue defects for medical purposes | ACTIVE | — |
| 010 | Breast implants, namely, artificial breast implants; Artificial breast implants; Biodegradable implants, namely, biodegradable bone fixation implants, biodegradable stents, biodegradable meshes, biodegradable drug-eluting implants, biodegradable tissue scaffolds, biodegradable nerve conduits, biodegradable joint spacers and, biodegradable barriers or membranes; Surgical implants comprised of artificial materials; Osseous implants made of artificial materials; Medical implants, namely, hip implants, knee implants, dental implants, spinal implants, cardiac stents, intraocular lenses, joint replacements, vascular grafts, pelvic mesh implants, cranial implants, bone graft substitutes, intravascular coils, ocular implants, artificial heart valves, facial implants and synthetic ligaments, all composed of artificial materials; Medical implants made of artificial materials; Implant models, namely, surgical implants comprising artificial material; prosthetics, namely, prosthetic arms, prosthetic legs, prosthetic hands, prosthetic feet, prosthetic fingers, prosthetic toes, craniofacial prosthetics, ocular prosthetics, facial prosthetics, dental prosthetics, breast prosthetics and implants consisting of artificial materials; silicone prosthetic implants consisting of artificial materials; artificial organs, namely, artificial hearts, artificial kidneys, artificial pancreas, artificial livers, artificial lungs, cochlear implants, retinal implants, artificial corneas, artificial bladders, artificial esophagus, synthetic blood vessels and artificial tracheas; prosthetic implants for use in facial surgery; surgical and medical apparatus and instruments, for use in general surgery, spinal surgery, orthopedic surgery; sets of artificial teeth; artificial limbs; artificial eyes; orthopedic apparatus and instruments for diagnostic and therapeutic use; Surgical and medical apparatus and instruments for use in plastic cosmetic or plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue; surgical instruments, namely, drills, screwdrivers, reamers and hammers; suture materials; surgical instruments for use in anti-ageing prevention and treatment of glabellar lines, facial wrinkles, asymmetries, defects and diseases of the human skin, surgery and plastic surgery relating to the face, breasts and obesity in the field of dermatology, cosmetology, skin reconstruction and skin pigmentation; needles for medical purposes for use in introduction of fluid; skin implants with gel-like substances, of artificial material for medical purposes and used to fill wrinkles or to increase the volume of the skin; cases fitted for medical apparatus containing needles for introducing liquid into the skin; gel implants made of artificial materials for surgical purposes and for plastic surgery; fluid injectors filled with artificial material for implantation, for medical purposes; cases fitted for medical apparatus; hypodermic syringes; artificial skin for surgical purposes; syringes for injections for medical use | ACTIVE | — |
| 044 | Medical and healthcare services, namely, plastic surgery and microsurgery, wrinkle correction and elimination of sweating, raising of drooping eyebrows, lip augmentation, plastic surgery of the earlobes, rhinoplasty, plastic surgery of the face and neck, breast augmentation, breast modelling with reduction, abdominal reconstruction, intimate surgery, buttock forming, plastic surgery of the calves, fat removal, liposuction and combined liposuction, alternative kinds of liposuction; Online advisory services in relation to the medical and healthcare services, plastic surgery, microsurgery, and also hygienic and beauty care for human beings; Providing of information on websites relating to medical services, namely plastic surgery and microsurgery as well as hygienic and beauty care for human beings; Advisory services relating to the human hygiene and beauty care; Medical advisory services in the field of dermatology, injectable filler treatments for cosmetic purposes, health care services, human hygiene and beauty care, medical assistance, blood bank services, organ banks; Providing of information relating to the plastic surgery, facial surgery, breast surgery, surgical interventions, medical nursing, nursing home services, sanatorium services, beauty treatment salons, pharmacy advice, surgery using minimally invasive methods to treat congenital and involutional changes in human soft tissues and cosmetic facial defects; Providing of medical information and expert medical consultancy services to doctors and medical staff in the field of esthetic treatment services for the body and face | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 13, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 12, 2025 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Sep 12, 2025 | XAAP | EXAMINER'S AMENDMENT AFTER PUB APPROVAL | — |
| Sep 2, 2025 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 5, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 5, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 5, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 5, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 5, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 20, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 5, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 5, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 3, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 3, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 12, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 12, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 12, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 16, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 14, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 24, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 24, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 9, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 8, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 9, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 5, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 4, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |